Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with diffuse large B cell lymphoma or follicular lymphoma (confirmed by a tissue sample test, classified according to WHO 2016 guidelines) and whose doctor has recommended a first course of treatment using a regimen called RCHOP 21
- People who have agreed to take part after receiving both spoken and written information about the study
Who may not be able to join:
- People who have previously received any treatment for lymphoma (with the exception of a small, targeted course of low-dose radiotherapy for follicular lymphoma)
- People who are being treated with a chemotherapy plan other than RCHOP 21
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 1 42 11 42 40
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prospective quantitative analysis of the level of circulating nucleosomes at baseline and during treatment in patients with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.